State Street
SNTI icon

State Street’s Senti Biosciences Holdings SNTI Stock Holding History

State Street’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.13K Hold
10,010
– – ﹤0.01% 4257
2025
Q4 		$10.4K Hold
10,010
– – ﹤0.01% 4267
2025
Q3 		$14.1K Hold
10,010
– – ﹤0.01% 4263
2025
Q2 		$21.1K Hold
10,010
– – ﹤0.01% 4199
2025
Q1 		$33.6K Hold
10,010
– – ﹤0.01% 4147
2024
Q4 		$35.1K Buy
+10,010
New +$31.9K ﹤0.01% 4163
2024
Q3 		– Sell
-3,910
Closed -$10.8K – 4333
2024
Q2 		$10.8K Hold
3,910
– – ﹤0.01% 4320
2024
Q1 		$14.7K Hold
3,910
– – ﹤0.01% 4314
2023
Q4 		$25.8K Hold
3,910
– – ﹤0.01% 4316
2023
Q3 		$16.6K Hold
3,910
– – ﹤0.01% 4467
2023
Q2 		$24.4K Hold
3,910
– – ﹤0.01% 4569
2023
Q1 		$46.1K Hold
3,910
– – ﹤0.01% 4519
2022
Q4 		$55.1K Buy
+3,910
New +$95.4K ﹤0.01% 4538

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State Street's SNTI Position: Q1 2026 in Review

State Street held its Senti Biosciences Holdings (SNTI) position steady in Q1 2026 at 10,010 shares worth $8.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4257.

State Street first reported a position in SNTI in Q4 2022 and has held it in 13 quarters since. The position peaked at $55.1K in Q4 2022. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • State Street held 10,010 shares of Senti Biosciences Holdings worth $8.13K as of Q1 2026.
  • State Street left its Senti Biosciences Holdings share count unchanged in Q1 2026.
  • Senti Biosciences Holdings made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4257 holding.
  • State Street first reported a position in Senti Biosciences Holdings in Q4 2022 and has held it in 13 quarters since.
  • State Street's Senti Biosciences Holdings position peaked at $55.1K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.